Recombinant peptides for gastrointestinal ulceration: still early days.
Playford
R J
RJ
University Division of Gastroenterology, Leicester General Hospital NHS Trust.
D003365:Costs and Cost Analysis; D004815:Epidermal Growth Factor / Q000627:therapeutic use*; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D004815:Epidermal Growth Factor